TY - JOUR
T1 - Effects of NO donors and synthase agonists on endothelial cell uptake of L-Arg and superoxide production
AU - Ogonowski, Alison A.
AU - Kaesemeyer, Wayne H.
AU - Jin, Liming
AU - Ganapathy, Vadivel
AU - Leibach, Fredrick H.
AU - Caldwell, R. William
PY - 2000
Y1 - 2000
N2 - It is commonly believed that the activity of NO synthase (NOS) solely controls NO production from its substrates, L-Arg and O2. The Michaelis- Menten constant (K(m)) of NOS for L-Arg is in the micromolar range; cellular levels of L-Arg are much higher. However, evidence strongly suggests that cellular supply of L-Arg may become limiting and lead to reduced NO and increased superoxide anion (O2/-·) formation, promoting cardiovascular dysfunction. Uptake of L-Arg into cells occurs primarily (~85%) through the actions of a Na+-independent, carrier-mediated transporter (system y+). We have examined the effects of NOS agonists (substance P, bradykinin, and ACh) and NO donors (S-nitroso-N-acetyl-penicillamine and dipropylenetriamine NONOate) on transport of L-Arg into bovine aortic endothelial cells (BAEC). Our results demonstrate that NOS agonists increase y+ transporter activity. A rapidly acting NO donor initially increases L-Arg uptake; however, after longer exposure, L-Arg uptake is suppressed. Exposure of BAEC without L-Arg to substance P and a Ca2+ ionophore (A-23187) increased O2/-· formation, which was blocked with concurrent presence of L-Arg or the NOS antagonist N(ω)-nitro-L-arginine methyl ester. We conclude that factors including NO itself control y+ transport function and the production of NO and O2/-·.
AB - It is commonly believed that the activity of NO synthase (NOS) solely controls NO production from its substrates, L-Arg and O2. The Michaelis- Menten constant (K(m)) of NOS for L-Arg is in the micromolar range; cellular levels of L-Arg are much higher. However, evidence strongly suggests that cellular supply of L-Arg may become limiting and lead to reduced NO and increased superoxide anion (O2/-·) formation, promoting cardiovascular dysfunction. Uptake of L-Arg into cells occurs primarily (~85%) through the actions of a Na+-independent, carrier-mediated transporter (system y+). We have examined the effects of NOS agonists (substance P, bradykinin, and ACh) and NO donors (S-nitroso-N-acetyl-penicillamine and dipropylenetriamine NONOate) on transport of L-Arg into bovine aortic endothelial cells (BAEC). Our results demonstrate that NOS agonists increase y+ transporter activity. A rapidly acting NO donor initially increases L-Arg uptake; however, after longer exposure, L-Arg uptake is suppressed. Exposure of BAEC without L-Arg to substance P and a Ca2+ ionophore (A-23187) increased O2/-· formation, which was blocked with concurrent presence of L-Arg or the NOS antagonist N(ω)-nitro-L-arginine methyl ester. We conclude that factors including NO itself control y+ transport function and the production of NO and O2/-·.
KW - Endothelial cells
KW - L-arginine uptake
KW - Nitric oxide
KW - Transporter regulation
KW - Vascular dysfunction
UR - http://www.scopus.com/inward/record.url?scp=0033976693&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0033976693&partnerID=8YFLogxK
U2 - 10.1152/ajpcell.2000.278.1.c136
DO - 10.1152/ajpcell.2000.278.1.c136
M3 - Article
C2 - 10644521
AN - SCOPUS:0033976693
SN - 0363-6135
VL - 278
SP - C136-C143
JO - American Journal of Physiology - Heart and Circulatory Physiology
JF - American Journal of Physiology - Heart and Circulatory Physiology
IS - 1 47-1
ER -